drugset / Trial / NCT04434365

Effect of Berberine for Endothelial Function and Intestinal Microflora in Patients With Coronary Artery Disease

NCT04434365

Phase 1/2 Unknown 24 enrolled Peking Union Medical College Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to conduct a single-center, randomized, open-label, controlled, dose-escalating, parallel-group study, evaluating the effects and change of endothelial function and gut microbiota after berberine administration in patients with stable coronary artery disease who are at \> 8 but ≤ 40 weeks after elective percutaneous coronary intervention

Timeline

Start
2019-06-21
Primary completion
2019-11-18
Completion
2020-12-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Berberine Traditional medicine (herbal / TCM) 300 mg
Background Aspirin Small molecule 100 mg
Background Atorvastatin Small molecule
Background Clopidogrel Small molecule 75 mg
Background Rosuvastatin Small molecule